| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $32.5M | +116.8% |
| SG&A Expense | $9.4M | +18.3% |
| Operating Income | -$41.8M | -82.8% |
| Income Tax | $0 | — |
| Net Income | -$41.1M | -96.4% |
| EPS (Basic) | -$2.26 | +16.9% |
| EPS (Diluted) | -$2.32 | +14.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.4M | +266.4% |
| Current Assets | $152.1M | +262.2% |
| Total Assets | $152.4M | +257.7% |
| Current Liabilities | $2.5M | +25.1% |
| Long-term Debt | $14.0M | +0.0% |
| Total Liabilities | $2.9M | -82.1% |
| Stockholders' Equity | $149.5M | +472.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.6M | -93.8% |
| Financing Cash Flow | $149.0M | +189.1% |